RCM
BIOA

RA Capital Management’s BioAge Labs BIOA Stock Holding History

RA Capital Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.9M Buy
+1,650,648
New +$31.8M 0.31% 46
2025
Q2 		– Sell
-1,052,494
Closed -$3.96M – 89
2025
Q1 		$3.96M Sell
1,052,494
-258,095
-20% -$1.19M 0.07% 79
2024
Q4 		$7.59M Sell
1,310,589
-900,000
-41% -$15.5M 0.1% 78
2024
Q3 		$46M Buy
+2,210,589
New +$44.3M 0.53% 39

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

RA Capital Management's BIOA Position: Q1 2026 in Review

RA Capital Management opened a new position in BioAge Labs (BIOA) in Q1 2026: 1,650,648 shares worth $28.9M. The stake represents 0.31% of the portfolio and ranks #46 among its holdings. This is a return to the name: RA Capital Management previously reported a position in BIOA as recently as Q1 2025.

RA Capital Management first reported a position in BIOA in Q3 2024 and has held it in 4 quarters since. The position peaked at $46M in Q3 2024. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • RA Capital Management held 1,650,648 shares of BioAge Labs worth $28.9M as of Q1 2026.
  • BioAge Labs was a new RA Capital Management position in Q1 2026.
  • BioAge Labs made up 0.31% of RA Capital Management's portfolio in Q1 2026, its #46 holding.
  • RA Capital Management first reported a position in BioAge Labs in Q3 2024 and has held it in 4 quarters since.
  • RA Capital Management's BioAge Labs position peaked at $46M in Q3 2024.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on RA Capital Management's 13F filing for Q1 2026, filed 15 May 2026.